FINEVISION
Trifocal IOL

WIN VISUAL ACUITIESFINEVISION

bvimedical.com

FINE TECHNOLOGY
The first and original patented diffractive trifocal optic

Combination of 2 profiles
The combination of two profiles* offers the patient an intermediate vision without impairing near and distancevisual acuities.
This concept was designed in order to reduce the loss of light energy that any diffractive system causes.

* Patented in Belgium: BE1019161 (A5), Europe: EP2503962 (B1), International: WO2011092169 (A1), United States of America: US 8,636,796 (B2), China: ZL201180002694.7, Japan:
5480980, Australia: 2011209315, Hong-Kong: 2503962

What do thestudies say?

Profile n°1

Diffraction orders

Profile n°2

FAR (eg. + 20D)

Order 0(determined by IOL curvature)

FAR (eg. + 20D)

NEAR + 3.5D

Order 1

INTERMEDIATE + 1.75D

LOST (not usable) + 7.0D

Order 2(always Order 1 doubled)

NEAR + 3.5D

"The second order of profile n° 2
reinforces order 1 of profile n° 1.
+ 3.5D

This gain of energy provides
more than 86% of useful light+ 1.75DH1(r)energy depending on the pupil

FineVision: +1.75D et + 3.5D

aperture."

Reference:H1(r)

H1(r)

rr

Data on file with PhysIOL.

r

Combination of 2 technologies
The FINE technology is the first and only optic that combines both Convolution and Apodization technologies
on the entire optic surface.

Innovative trifocal technology
Convolution and Apodization benefits
Convolution reduces and limits photopic phenomena.

What do thestudies say?

Histograms of halos for far focal point
Trifocal

100% 100% 100%

100%

Bifocal

EDOF

90%
80%

"The PSFs (Point of Spread

70%

Normalized intensity

Function) data show similar
halos intensity for FINE
technology and EDOF IOL."

60%
50%
40%
30%

Reference:20%

Data on file with PhysIOL.

10%0%
Central PSF

3.60% 3.16% 4.00%

1.50% 0.47% 1.00%

First halo

Second halo

Apodization optimizes the percentage of energy for far vision with the openingof the pupil.

What do thestudies say?

Light distribution (%) versus pupil diameter80

Far visionIntermediate vision (+ 1.75D)
Near vision (+ 3.5D)

70"To match the eye’s naturalreflex, the p­ ercentage of ­energy% Energy

60

allocated to the far ­vision increases

50with the opening of the pupil."

403020Reference:

10D. Gatinel, et al.: Design and0qualification of a diffractive trifocal

1.50

2.00

2.50

3.50

3.00

4.00

4.50

optical profile for intraocular lenses,

5.00

JCRS 2011; 37 : 2060-2067.

Aperture (mm)

FINE technology: best visual acuities at all distances
Defocus curve FineVision vs. bifocal and non-apodized trifocal IOLs

210-1-2-3-402

3B. Cochener, MD, PhD et al.: Clinicaloutcomes with a trifocal intraocular lens:a multicenter study, JRS 2014; 30 (11): 62768.
J. M. Martínez de la Casa, SEO 2014: Análisis
de la calidad visual tras implantación de lentes
intraoculares difractivas trifocales.
Soraya M.R. Jonker, MD et al.: Comparison ofa trifocal intraocular lens with a D3.0 D
bifocal IOL: Results of a prospective
randomized clinical trial, J Cataract Refract
Surg 2015; 41:1631–1640.

0.1
Visual Acuity (LogMAR)

1

0.2
0.3

R

0.4

Photopic

0.5
0.6
0.7
0.8

FineVision 1, 2, 3
Non-Apodized trifocal IOL 2
Apodized bifocal IOL + 3D 3

Defocus (diopters)

Mesopic

FINEVISION
Trifocal IOLs family

Please check the availability of the products on your market with your sales representative.

Note: The PhysIOL intraocular lenses are not FDA approved.

Contact Information:www.bvimedical.com/customer-support/
Content last reviewed 08/2020
BVI and all other trademarks (unless noted otherwise) are property of BVI. BVI ©2021

1581270-01